Global Photodynamic Therapy (PDT) Market 2024-2028
Global Photodynamic Therapy (PDT) Market 2024-2028
The photodynamic therapy (PDT) market is forecasted to grow by USD 2353.9 mn during 2023-2028, accelerating at a CAGR of 8.69% during the forecast period. The report on the photodynamic therapy (PDT) market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by high prevalence of cancer, increasing demand for personalized medicines, and strong pipeline and new drug approvals.
Technavio's photodynamic therapy (PDT) market is segmented as below:
- By Application
- Cancer
- Actinic keratosis
- Psoriasis
- Acne
- Others
- By Product
- Photosensitizer drugs
- Photodynamic therapy devices
- By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the increase in r and d and advances in technology as one of the prime reasons driving the photodynamic therapy (PDT) market growth during the next few years. Also, advancements in healthcare and medical sector and growing number of partnerships and collaborations on therapeutics will lead to sizable demand in the market.
The report on the photodynamic therapy (PDT) market covers the following areas:
- Photodynamic therapy (PDT) market sizing
- Photodynamic therapy (PDT) market forecast
- Photodynamic therapy (PDT) market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading photodynamic therapy (PDT) market vendors that include Bausch Health Companies Inc., Biofrontera AG, BIOLASE Inc., biolitec AG, Eufoton srl, Galderma SA, II VI Inc., IRIDEX Corp., Lotus Global Group Inc., LUMIBIRD SA, Lutronic Inc., Modulight Inc., Photocure ASA, Pinnacle Biologics Inc., Quanta System S.p.A., Soligenix Inc., SpectraCure AB, Sun Pharmaceutical Industries Ltd., SUS Advancing Technology Co. Ltd., and Theralase Technologies Inc.. Also, the photodynamic therapy (PDT) market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.